Related Experiment Video
Updated: Feb 7, 2026

Qualitative and Quantitative Validation of Tools with Rating Scales Aimed at Assessing the Quality of University Service-Learning
Published on: August 29, 2025
[Relevance of fluoroquinolones prescriptions in medical service]
C Lo Presti1, A Blaise2, M Maestracci1
1Service pharmacie, centre hospitalier de Salon-de-Provence, 13300 Salon-de-Provence, France.
Introduction:
Fluoroquinolones (FQ) are antibiotics which favour the emergence of resistance and remain widely prescribed in the French hospital environment. A focus of prescription recommendation was published by the French Infectious Diseases Society (SPILF) in 2015 in order to preserve their use. The pneumology-oriented medical service of Salon de Provence's hospital had high FQ consumption for the year 2015; thus a relevant assessment of prescriptions was carried out.
Methods:
This retrospective study was conducted between January 1 and December 31, 2015 and concerned patients who received at least one FQ administration during their hospitalization.
Results:
Thirty-eight per cent of the prescriptions were justified, 37 % were inappropriate and 25 % unjustified. The majority of unjustified prescriptions were for lung infections. Only 35 % of the patients received bacteriological documentation and 53 % of the prescriptions were reassessed at 48-72hours. Twenty-two per cent of the justified prescriptions showed non-conformities concerning the duration of prescriptions, the dosage or an association with another antibiotic.
Conclusion:
The diffusion of these results, combined with the implementation of corrective actions, should make it possible to improve the relevance of the FQ prescription.
Insights
Fluoroquinolone (FQ) antibiotic prescriptions in a French hospital were assessed, revealing only 38% were justified. Improving FQ prescribing practices is crucial to combat antibiotic resistance.
Area of Science:
- Infectious Diseases
- Pharmacology
- Hospital Pharmacy
Background:
- Fluoroquinolones (FQ) are widely used antibiotics associated with resistance.
- A 2015 French guideline aimed to preserve FQ utility.
- High FQ consumption in a hospital pneumology service prompted an assessment.
Purpose of the Study:
- To evaluate the appropriateness of fluoroquinolone prescriptions.
- To identify areas for improvement in FQ prescribing practices.
Main Methods:
- Retrospective study of FQ prescriptions from January 1 to December 31, 2015.
- Analysis of prescription justification, bacteriological documentation, and reassessment rates.
Main Results:
- Only 38% of FQ prescriptions were justified; 25% were unjustified, primarily for lung infections.
- Bacteriological documentation was present in only 35% of cases.
- 53% of prescriptions were reassessed within 48-72 hours, with non-conformities noted in 22% of justified prescriptions.
Conclusions:
- Significant improvements are needed in FQ prescription relevance.
- Disseminating findings and implementing corrective actions can enhance FQ prescribing.
- Optimizing FQ use is essential for antimicrobial stewardship.
More Related Videos
08:31Candida albicans Biofilm Development on Medically-relevant Foreign Bodies in a Mouse Subcutaneous Model Followed by Bioluminescence Imaging
Published on: January 27, 2015
06:59A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Related Concept Videos
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Inhaled Medications
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Preventive Healthcare Services
Endocarditis III: Medical Management
Myocarditis III: Medical Management